Similar articles for PMID: 9225812

Year	Number of Results
1969	1
1971	1
1987	1
1988	1
1989	2
1990	2
1991	1
1992	4
1993	2
1994	3
1995	6
1997	2
1998	3
1999	6
2000	3
2001	6
2002	3
2003	3
2004	2
2005	7
2006	5
2007	2
2008	10
2009	10
2010	7
2011	7
2012	5
2013	7
2014	7
2015	8
2016	4
2017	3
2018	2
2019	6
2020	4
2021	2

1

Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Fujibayashi Y, et al. J Nucl Med. 1997 Jul;38(7):1155-60. J Nucl Med. 1997. PMID: 9225812 Free article.

2

Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).

Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R, Kovacs A, Gropler RJ, Welch MJ. Lewis JS, et al. J Nucl Med. 2002 Nov;43(11):1557-69. J Nucl Med. 2002. PMID: 12411560 Free article.

3

Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Yuan H, et al. J Nucl Med. 2006 Jun;47(6):989-98. J Nucl Med. 2006. PMID: 16741309 Free article.

4

Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.

Handley MG, Medina RA, Mariotti E, Kenny GD, Shaw KP, Yan R, Eykyn TR, Blower PJ, Southworth R. Handley MG, et al. J Nucl Med. 2014 Mar;55(3):488-94. doi: 10.2967/jnumed.113.129015. Epub 2014 Jan 13. J Nucl Med. 2014. PMID: 24421288 Free PMC article.

5

Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.

Burgman P, O'Donoghue JA, Lewis JS, Welch MJ, Humm JL, Ling CC. Burgman P, et al. Nucl Med Biol. 2005 Aug;32(6):623-30. doi: 10.1016/j.nucmedbio.2005.05.003. Nucl Med Biol. 2005. PMID: 16026709

6

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.

Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Ann Nucl Med. 2001 Dec;15(6):499-504. doi: 10.1007/BF02988502. Ann Nucl Med. 2001. PMID: 11831397

7

Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.

Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM. Valtorta S, et al. J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22. J Nucl Med. 2013. PMID: 23699667 Free article.

8

Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.

Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T, Yoshii H, Oyama N, Okazawa H, Saga T, Fujibayashi Y. Yoshii Y, et al. Nucl Med Biol. 2012 Feb;39(2):177-85. doi: 10.1016/j.nucmedbio.2011.08.008. Epub 2011 Oct 26. Nucl Med Biol. 2012. PMID: 22033022

9

Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.

Takahashi N, Fujibayashi Y, Yonekura Y, Welch MJ, Waki A, Tsuchida T, Sadato N, Sugimoto K, Nakano A, Lee JD, Itoh H. Takahashi N, et al. Ann Nucl Med. 2001 Jun;15(3):293-6. doi: 10.1007/BF02987849. Ann Nucl Med. 2001. PMID: 11545205

10

Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats.

Fujibayashi Y, Cutler CS, Anderson CJ, McCarthy DW, Jones LA, Sharp T, Yonekura Y, Welch MJ. Fujibayashi Y, et al. Nucl Med Biol. 1999 Jan;26(1):117-21. doi: 10.1016/s0969-8051(98)00049-3. Nucl Med Biol. 1999. PMID: 10096511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed